Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-03

Clinical Trial Update: Comparison of the Effects of Bimatoprost and a Fixed Combination of Latanoprost and Timolol on 24-hour Blood and Ocular Perfusion Pressures [Phase 3]

View source ↗

Summary

This Phase 3 trial compared bimatoprost to a fixed combination of latanoprost and timolol for effects on 24-hour blood and ocular perfusion pressures in glaucom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumigan (bimatoprost)
  • Xalacom (latanoprost/timolol)

Snippet

Sponsor: University of Milan | Conditions: Glaucoma | Phase 3 | Status: COMPLETED